Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)

NCT01401023 is registered in ClinicalTrials.gov with Gary E. Stein, Pharm.D. as lead sponsor.

NCT NCT01401023
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01401023 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pharmacokinetics and Safety of Tigecycline in the Treatment of Clostridium Difficile Associated Diarrhea (CDAD)
Lead sponsor
Gary E. Stein, Pharm.D.
Phase
Not applicable
Overall status
Completed
Start date
July 31, 2011
Completion date
July 31, 2013
Enrollment
10 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

clostridium difficile, diarrhea